DEUTSCHE BANK AG\ - BIOSCRIP INC ownership

BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 131 filers reported holding BIOSCRIP INC in Q4 2013. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of BIOSCRIP INC
ValueSharesWeighting
Q2 2019$10,705,000
+82.4%
4,118,169
+40.3%
0.01%
+100.0%
Q1 2019$5,868,000
+127.1%
2,935,010
+305.2%
0.00%
+50.0%
Q4 2018$2,584,000
-77.0%
724,410
-80.0%
0.00%
-33.3%
Q3 2018$11,241,000
-32.2%
3,626,528
-36.0%
0.00%
-40.0%
Q2 2018$16,590,000
+81.8%
5,662,467
+52.7%
0.01%
+25.0%
Q1 2018$9,123,000
+0.2%
3,709,125
+18.5%
0.00%
-33.3%
Q4 2017$9,106,000
+4.3%
3,129,352
-1.4%
0.01%0.0%
Q3 2017$8,728,000
+23.2%
3,174,413
+21.6%
0.01%
+20.0%
Q2 2017$7,085,000
+65.7%
2,609,965
+3.7%
0.01%
+66.7%
Q1 2017$4,276,000
+50.9%
2,515,926
-7.7%
0.00%
+50.0%
Q4 2016$2,833,000
-28.0%
2,725,716
+100.1%
0.00%
-33.3%
Q3 2016$3,935,000
+45.4%
1,362,188
+28.2%
0.00%
+50.0%
Q2 2016$2,707,000
+12790.5%
1,062,273
+10422.8%
0.00%
Q1 2016$21,000
-70.8%
10,095
-75.9%
0.00%
Q4 2015$72,000
-64.0%
41,850
-61.1%
0.00%
Q3 2015$200,000
-77.7%
107,638
-56.5%
0.00%
-100.0%
Q2 2015$897,000
+101.6%
247,441
+145.1%
0.00%
Q1 2015$445,000
-37.2%
100,961
-0.6%
0.00%
Q4 2014$709,000
+104.9%
101,593
+102.1%
0.00%
Q3 2014$346,000
-81.5%
50,278
-77.7%
0.00%
-100.0%
Q2 2014$1,874,000
+11.2%
224,970
-6.9%
0.00%0.0%
Q1 2014$1,685,000
+497.5%
241,528
+531.5%
0.00%
Q4 2013$282,000
-67.7%
38,244
-61.7%
0.00%
-100.0%
Q3 2013$874,00099,7330.00%
Other shareholders
BIOSCRIP INC shareholders Q4 2013
NameSharesValueWeighting ↓
Venor Capital Management LP 12,005,453$20,409,00010.92%
Coliseum Capital Management, LLC 5,622,410$9,558,0004.30%
Alta Fundamental Advisers LLC 2,217,164$3,769,0004.07%
WYNNEFIELD CAPITAL INC 3,800,000$6,460,0002.37%
ARDSLEY ADVISORY PARTNERS LP 5,280,000$8,976,0001.40%
NORTH TIDE CAPITAL, LLC 3,000,000$5,100,0000.78%
Camber Capital Management LP 10,180,000$17,306,0000.70%
PERKINS CAPITAL MANAGEMENT INC 310,500$528,0000.54%
ROANOKE ASSET MANAGEMENT CORP/ NY 233,280$397,0000.19%
Eidelman Virant Capital 140,000$238,0000.16%
View complete list of BIOSCRIP INC shareholders